The Finnish EU presidency kicked off in the very first days of July with very little pomp and circumstance; instead of grand galas, the Finns were made part of the process by Government organising a popular festival. Finland’s attitude to its presidency period is matter-of-fact and pragmatically goal-directed. This will, by no means, be an easy period, with all the particular aspects involved: there will be the call to order of the new European Parliament, various appointments, Brexit and the new Commission taking office for its five-year term.
Breakfast Discussion Tuesday 15 October at the European Parliament, Brussels
The pharmaceutical industry sees the Finnish EU Presidency as an opportunity to promote the European competitiveness
The pharmaceutical industry sees the Finnish EU Presidency as an opportunity to promote the European competitiveness. The agenda for the forthcoming EU Commission will include important issues related to research, innovations and the industrial policy.
3rd Nordic conference will facilitate and bring forward ideas for discussion in order to accelerate medicine development for children, by providing most appropriate context for new solutions, and updating the current information related to pediatric Clinical Trials.
Syöpäsäätiö (Cancer Foundation) and thirty-two other research actors provided the parliamentary groups with their appeal for enhanced medical research.